| Olivia E Morris, DO | |
|
10511 Golf Course Rd Nw Ste 204, Albuquerque, NM 87114-5917 | |
| (505) 727-4430 | |
| Not Available |
| Full Name | Olivia E Morris |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 28 Years |
| Location | 10511 Golf Course Rd Nw Ste 204, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619998267 | NPI | - | NPPES |
| 5550830009 | Other | AZ | MEDICARE NSC AZ NORTH |
| 16587090 | Medicaid | NM | |
| 5550830001 | Other | AZ | MEDICARE NSC SCW |
| Z226497 | Other | AZ | MEDICARE PTAN |
| 5550830004 | Other | AZ | MEDICARE NSC PV |
| 5550830003 | Other | AZ | MEDICARE NSC PEORIA |
| 5550830007 | Other | AZ | MEDICARE NSC DV |
| 5550830008 | Other | AZ | MEDICARE NSC SWV |
| 5550830006 | Other | AZ | MEDICARE NSC ANTHEM |
| 882515 | Medicaid | AZ | |
| 5550830010 | Other | AZ | MEDICARE NSC GILBERT |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lovelace Westside Hospital | Albuquerque, NM | Hospital |
| Lovelace Medical Center | Albuquerque, NM | Hospital |
| Lovelace Women's Hospital | Albuquerque, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Medical Associates, Llc | 7214831114 | 291 |
News Archive
Crowding in hospital emergency departments has led to a decrease in the timely and effective use of pain medication in children suffering acute long bone fractures, according to a new study by the University of Colorado School of Medicine.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
A new £120 million national network of Quantum Technology Hubs, that will explore the properties of quantum mechanics and how they can be harnessed for use in technology, has been unveiled today at the University of Birmingham.
Roche and the US-based biopharmaceutical company Alnylam Pharmaceuticals, Inc. announced today that they have entered into a major alliance in which Roche obtains a non-exclusive license to Alnylam's technology platform for developing RNAi (RNA interference) therapeutics.
› Verified 2 days ago
| Entity Name | Southwest Medical Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164491072 PECOS PAC ID: 7214831114 Enrollment ID: O20031121000724 |
News Archive
Crowding in hospital emergency departments has led to a decrease in the timely and effective use of pain medication in children suffering acute long bone fractures, according to a new study by the University of Colorado School of Medicine.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
A new £120 million national network of Quantum Technology Hubs, that will explore the properties of quantum mechanics and how they can be harnessed for use in technology, has been unveiled today at the University of Birmingham.
Roche and the US-based biopharmaceutical company Alnylam Pharmaceuticals, Inc. announced today that they have entered into a major alliance in which Roche obtains a non-exclusive license to Alnylam's technology platform for developing RNAi (RNA interference) therapeutics.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Olivia E Morris, DO 4101 Indian School Rd Ne Ste 110, Albuquerque, NM 87110-3991 Ph: (505) 727-4430 | Olivia E Morris, DO 10511 Golf Course Rd Nw Ste 204, Albuquerque, NM 87114-5917 Ph: (505) 727-4430 |
News Archive
Crowding in hospital emergency departments has led to a decrease in the timely and effective use of pain medication in children suffering acute long bone fractures, according to a new study by the University of Colorado School of Medicine.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
A new £120 million national network of Quantum Technology Hubs, that will explore the properties of quantum mechanics and how they can be harnessed for use in technology, has been unveiled today at the University of Birmingham.
Roche and the US-based biopharmaceutical company Alnylam Pharmaceuticals, Inc. announced today that they have entered into a major alliance in which Roche obtains a non-exclusive license to Alnylam's technology platform for developing RNAi (RNA interference) therapeutics.
› Verified 2 days ago
Dr. Carl Jan Gilmore, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: Msc08 4770, 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-6472 | |
Shelby Edward Jarrell Iii, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 201 Cedar St Se, Suite 6600, Albuquerque, NM 87106 Phone: 505-724-4300 Fax: 505-724-4384 | |
Clayton B Conrad, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 201 Cedar St Se, Suite 6600, Albuquerque, NM 87106 Phone: 505-724-4300 Fax: 505-724-4384 | |
Dr. Douglas George Orndorff, M.D Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2100 Louisiana Blvd Ne Ste 410, Albuquerque, NM 87110 Phone: 505-724-4300 Fax: 505-724-4384 | |
Dr. Samer Kakish, FRCS(TR & ORTH), MSC Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 University Of New Mexico, Department Of Orthopaedics, Albuquerque, NM 87131 Phone: 505-272-4107 Fax: 505-272-8098 | |
Kari M Babinski, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 201 Cedar St Se, Suite 6600, Albuquerque, NM 87106 Phone: 505-724-4300 Fax: 505-724-4384 | |
Michael E Mccutcheon, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 201 Cedar St Se, Suite 6600, Albuquerque, NM 87106 Phone: 505-724-4300 Fax: 505-724-4384 |